INTENT TO SOLE SOURCE NASM 6 20 2023.pdf
PDF 252 KB Posted
- Solicitation number
- FDA_6202023
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Draft_Rare Diseases Study_SOW_8 May 2023.docx updated 6 20 2023.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
June 20th, 2023
Notice of Intent to Sole Source National Academy of
Sciences
FDA_6202023
The Food and Drug Administration (FDA) intends to award a Sole Source cost reimbursement contract order to National Academy of Sciences, 500 Fifth Street NW, Washington DC 20001. In accordance with FAR Part 6.302- 5 (c) (B) Authorized or Required by Statutes. To any contract requiring the National Academy of Sciences to investigate, examine, or experiment upon any subject of science or art of significance to an executive agency and to report on those matters to the Congress or any agency of the Federal Government.
The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a cost reimbursement contract.
MINIMUM REQUIREMENTS:
Specific Tasks/Deliverables
See Attached Statement of Work
This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.
Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.
It is anticipated that an award will be issued to National Academy of Science within approximately ten (10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.
Response Date: June 22, 2023, by 11AM EST. Please email responses to Howard S. Yablon – howard.yablon@fda.hhs.gov.
Howard S. Yablon Contracting Officer mailto:howard.yablon@fda.hhs.gov.
| 2023-06-20T10:18:31-0400 | |
| Howard S. Yablon -S |
File details come from the government source that posted it. Updated .